Drug archive
Ipratropium (Inhalation)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Bronchodilator
Description
Ipratropium (I-pra-TROE-pee-um) is a bronchodilator (medicine that opens up narrowed breathing passages). It is taken by inhalation to help control the symptoms of lung diseases, such as asthma, chronic bronchitis, and emphysema. Ipratropium helps decrease coughing, wheezing, shortness of breath, and troubled breathing by increasing the flow of air into the lungs.
When ipratropium inhalation is used to treat acute, severe attacks of asthma, bronchitis, or emphysema, it is used only in combination with other bronchodilators.
Ipratropium is available only with your doctor's prescription, in the following dosage forms:
- Inhalation aerosol (U.S. and Canada)
- Inhalation solution (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Atrovent
In Canada -
- Apo-Ipravent
- Atrovent
- Kendral-Ipratropium